Position in GRFS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,416,856
-$262,307 QoQ
Shares Held
200,121
-4.4% QoQ
Ownership
0.029%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#39
of 164 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HANTZ FINANCIAL SERVICES, INC. holds $94,295,990 across 14 Drug Manufacturers - General names. GRFS ranks #12 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
84,317 | $21,413,988 | |
| 2 | LLY |
ELI LILLY & Co
|
10,017 | $12,014,691 | |
| 3 | ABBV |
AbbVie Inc.
|
45,381 | $11,419,674 | |
| 4 | NVS |
Novartis AG
|
68,779 | $10,779,044 | |
| 5 | MRK |
Merck & Co., Inc.
|
66,636 | $8,562,726 | |
| 6 | GSK |
GSK plc
|
159,568 | $8,364,554 | |
| 7 | NVO |
Novo Nordisk A S
|
117,306 | $5,623,649 | |
| 8 | AZN |
Astrazeneca PLC
|
23,610 | $4,476,928 |
All Filings in GRFS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,416,856 | 200,121 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,679,163 | 209,372 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,982,499 | 212,032 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $2,230,960 | 223,992 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $2,062,955 | 228,203 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $1,651,155 | 232,230 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $1,745,163 | 234,565 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $2,147,290 | 241,812 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,235,592 | 195,815 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $1,159,968 | 173,648 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $2,031,635 | 175,747 | Shares | Sole | 2024-08-06 | |
| 2023-09-30 | $1,656,067 | 181,189 | Shares | Sole | 2024-08-06 | |
| 2023-06-30 | $1,633,539 | 178,334 | Shares | Sole | 2024-08-06 | |
| 2023-03-31 | $1,299,456 | 176,317 | Shares | Sole | 2024-08-06 | |
| 2022-12-31 | $1,443,045 | 169,770 | Shares | Sole | 2024-08-06 | |
| 2022-09-30 | $1,043,744 | 169,439 | Shares | Sole | 2024-08-06 | |
| 2022-06-30 | $1,990,173 | 167,523 | Shares | Sole | 2024-08-06 | |
| 2022-03-31 | $1,841,655 | 157,676 | Shares | Sole | 2024-08-06 | |
| 2021-12-31 | $1,604,149 | 142,845 | Shares | Sole | 2024-08-06 | |
| 2021-09-30 | $1,586,003 | 108,556 | Shares | Sole | 2024-08-06 | |
| 2021-06-30 | $1,301,423 | 75,010 | Shares | Sole | 2024-08-06 | |
| 2021-03-31 | $922,179 | 53,336 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||